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INTRODUCTION 
    
  The commercial IAM.PC.DD2 column was compared to a 
  cholester and a new SPM column towards log BB prediction. 
  All three models performed very good, illustrating that these 
  three columns can be used for this kind of  modeling. 
  Other (phospho)lipid-like stationary phases should be            
    developed and tested for prediction of  log BB values.  
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Figure 1: Schematic representation of  drug interactions in 
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RESULTS & DISCUSSION 
CONCLUSION 
EXPERIMENTAL 
IAM.PC.DD2 
Measurements were performed on three IAM-columns, namely an 
IAM.PC.DD2 column (10 µm, 150 x 4.6 mm), a Cholester column (5 µm, 250 
x 4.6 mm) and an in-house synthesized Sphingomyelin column (150 x 3 mm) 
[3]. The mobile phase flow rate was 1 ml/min, except for the Sphingomyelin 
column, where a flow rate of 0.5 ml/min was used. The mobile phase was a 
mixture of methanol and Dulbecco’s Phosphate-Buffered Saline (DPBS). 
IAM 
The retention factors (k) of the compounds were measured. A Partial Least 
Squares (PLS) regression was performed in order to determine the correlation 
coefficient (R) between actual (in vivo) log BB values and log BB values 
predicted using log k values and several molecular descriptors. The most 
relevant descriptors were selected by systematic removal and/or reinsertion of 
all descriptors from the models while monitoring the effect on the Leave-One-
Out Cross-Validation (LOOCV) regression coefficients. 
Log BB 
The results from the PLS and LOOCV regressions before and after 
elimination of superfluous molecular descriptors are presented in Table 1. The 
large difference in correlation coefficient in Table 1A is an indication of 
overfitting in the model. By removing unnecessary descriptors, the overfitting 
was reduced a lot (Table 1B). For all three columns, a correlation coefficient 
of ± 0.80 was obtained, indicating a good log BB prediction. 
The correlation between actual and predicted log BB values is illustrated in 
Figure 3 for all columns before and after optimization. Although there are a 
few outsiders, the predicted log BB values for most compounds are close to 
the actual (in vivo) determined values.  
Table 1: Correlation coefficients between actual and predicted log BB values using PLS and LOOCV (A) before and (B) after 
optimization of  molecular descriptors. 
Prediction of  log BB values 
The coefficients of the equations 
obtained from PLS regressions that 
lead to the R values listed in Table 1B, 
are listed in Table 2. Except for the log 
k values, all descriptor values are 
available in literature or can be 
calculated.  
Figure 3: Visual representation of  the correlation between Actual and Predicted log BB values using the LOOCV method before 
and after elimination of  superfluous molecular descriptors 
Table 2: Coefficients generated by PLS regression after 
elimination of  superfluous descriptors. The general equation 
for the predicted log BB values is:  
log BB = a + b×α + c×Pr + d×HIA + e×log k 
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In this study, the performance of 
three stationary phases for 
immobilized artificial membrane 
(IAM) liquid chromatographic 
approaches were compared on 
a set of 49 compounds. All data 
were correlated with actual log 
BB values and the relative 
performance of the approaches 
was studied. 
 
IAMs mimic the lipid envi-
ronment of a cell membrane by 
anchoring synthetic (phospho)-
lipid analogues at monolayer 
density to silica particles. These 
particles are subsequently used 
as a column packing material 
for HPLC [2]. The drug 
interactions in IAM-LC are 
presented in Figure 1. 
IAM.PC.DD2  
30 % MeOH 
Cholester 
50 % MeOH 
SPM 
30 % MeOH 
R (PLS) 0.8772 0.8604 0.8701 
R (LOOCV) 0.6231 0.5620 0.6064 
(A) 
IAM.PC.DD2  
30 % MeOH 
Cholester 
50 % MeOH 
SPM 
30 % MeOH 
R (PLS) 0.8542 0.8303 0.8429 
R (LOOCV) 0.8129 0.7750 0.7994 
(B) 
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IAM.PC.DD2  
30 % MeOH 
Cholester 
50 % MeOH 
SPM 
30 % MeOH 
a -2.831 -3.374 -2.750 
b 0.444 0.735 0.653 
c -0.003 -0.002 -0.003 
d 0.042 0.044 0.039 
e 0.703 0.629 0.706 
To illustrate the difference 
in retention behavior (and 
thus also log BB 
prediction) of the 
columns, chromatograms 
obtained for three 
compounds are given in 
Figure 2. 
There is no particular 
elution order for 
compounds on these 
columns, which is an 
indication of the 
difference in selectivity. 
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Figure 2: Chromatograms obtained by analyses of  clonidine, halothane and 
ibuprofen on an IAM.PC.DD2, a Cholester and a SPM column. 
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